Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of 171.43 million as of January 3, 2025. Its market cap has increased by 118.83% in one year.

Market Cap

171.43M

Enterprise Value

206.73M

Revenue

6.71M

Ranking

n/a

PE Ratio

n/a

Stock Price

8.81

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 309.05M to 171.43M, a decrease of -44.53%. That is a compound annual growth rate of -3.21%.

Market Cap History

Date	Market Cap	% Change
Jan 3, 2025	171.43M	-1.56%
Dec 30, 2024	174.16M	97.16%
Dec 29, 2023	88.33M	219.35%
Dec 30, 2022	27.66M	-4.32%
Dec 30, 2021	28.91M	-24.65%
Dec 30, 2020	38.37M	-66.14%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Roche Holding AG	205.19B
Novartis AG	177.34B
Lonza Group AG	38.70B
Alcon	38.03B
Galderma Group AG	23.91B
Straumann Holding AG	18.22B
Sonova Holding AG	17.66B
Sandoz Group AG	16.31B

Market Cap Rankings